Michael Vasconcelles Immuno Gen, Inc. (IMGN) insider trading activity

Michael Vasconcelles is EVP R&D & MEDICAL AFFAIRS of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 1,327 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

MICHAEL VASCONCELLES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 12 2024	SELL Sale (or disposition) back to the issuer	-	1,327 Reduced 100.0%	0 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$21,245 $16.01 p/Share	1,327 Added 50.0%	1,327 Common Stock

Also insider at

MGTA

Magenta Therapeutics, Inc. Healthcare

Director

KURA

Kura Oncology, Inc. Healthcare